Financials
Financial year 2025
ENDOCRINE SOCIETY DEVELOPMENT from Houffalize, company number BE0882241922, closed financial year 2025 with a result of € 151,962 after tax. For that financial year ENDOCRINE SOCIETY DEVELOPMENT recorded a gross margin of € 242,923 and equity of € 644,152. Compared with financial year 2024, the result moved from € 83,506 to € 151,962. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.
€ 644,152
▲ 13% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 151,962
▲ 82% vs 2024
Profit after tax over the fiscal year.
€ 154,244
▼ 27% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 78,750 paid out
52 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 91,412
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 87,514
▼ 21% vs 2024
€ 26,483 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 2,838
▼ 27% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 32,105
▲ 231% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 146,228 | € 162,085 | € 143,753 | € 242,923 | ▲ 69% |
| Profit after taxes | € 84,799 | € 100,849 | € 83,506 | € 151,962 | ▲ 82% |
| Equity | € 517,486 | € 555,995 | € 570,941 | € 644,152 | ▲ 13% |
| Total debts | € 227,924 | € 212,940 | € 193,508 | € 201,495 | ▲ 4% |
| Cash | € 166,046 | € 153,946 | € 210,105 | € 154,244 | ▼ 27% |
| Land & buildings | € 408,654 | € 389,301 | € 369,949 | € 353,068 | ▼ 5% |
| Retained profit | € 505,086 | € 543,595 | € 558,541 | € 631,752 | ▲ 13% |
| Dividend | € 60,000 | € 62,340 | € 68,560 | € 78,750 | ▲ 15% |
| Bank debt | € 155,212 | € 133,529 | € 110,975 | € 87,514 | ▼ 21% |
| Balance sheet total | € 766,458 | € 788,875 | € 783,280 | € 862,328 | ▲ 10% |
Key figures of ENDOCRINE SOCIETY DEVELOPMENT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to ENDOCRINE SOCIETY DEVELOPMENT?
What happened at ENDOCRINE SOCIETY DEVELOPMENT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 151,962 (▲ 82% vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
In short
From € 84,799 profit in 2022 to € 151,962 profit in 2025.
Paid € 187,501 in corporate taxes since 2022.
Best year ever: 2025, with € 151,962 profit.
Paid out € 269,650 in dividends to the owners in total.
Management
Behind ENDOCRINE SOCIETY DEVELOPMENT is Sophie Brochier.
Directors
According to the 2025 annual accounts
Sophie Brochier
Director
Establishments
Establishment units
Physical locations of this company
Ollomont, Nadrin 28
6660 Houffalize
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0882.241.922
- VAT number
- BE 0882.241.922
- Registered office
- Ollomont, Nadrin 28, 6660 Houffalize
- Names & denominations
- ENDOCRINE SOCIETY DEVELOPMENT · ESD
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 July 2006
- Peppol
- Active · Active since 24 Sept 2025